EPIICAL

EPIICAL

Early treated Perinatally HIV Infected individuals: Improving Children’s Actual Life

The EPIICAL Consortium, funded by an unrestricted industry grant, aims to implement a predictive platform for the early identification of novel therapeutic strategies for HIV infected children.

This involves developing and applying statistical and mathematical modelling to data derived from cohorts of early treated infants and children to identify virological, immunological and transcriptomic profiles associated with early control of HIV infection after ART initiation as well as viral control following ART interruption. As coordinator, PENTA provides general project leadership and coordination at scientific and technical levels, as well as co-leading the design and implementation of proof of concept study protocols.

Go to website